Collaborations That Transform – Emerging Opportunities in Multiple Sclerosis and Neurosciences
7:30am - 9:30am
Dear Colleagues and Friends,
Can we build a roadmap to conquer Multiple Sclerosis (MS), a disease that impacts more than 2 million globally as the leading non-traumatic disability disorder in young adults? How have lessons learnt so far shed light on broader neuroscience R&D?
On September 24, join us for “Emerging Opportunities in Multiple Sclerosis and Neurosciences,” the fourth episode in our “Collaborations That Transform” webinar series.
AGENDA (Eastern Daylight Time)
Hui Cai, VP and Head of Content, WuXi AppTec, Program Chair
10:30 – 10:50 Session I: Meeting the Challenges in MS and Neuroscience Drug Development
A conversation with Dietmar Berger, Head of Development and CMO, Sanofi; moderated by Kevin Da Silva, Chief Editor, Nature Neuroscience
10:50 – 11:35 Session II: Clinical Prospects for a Challenging Disease: MS
Mark Freedman, Professor of Neurology, University of Ottawa; Sr. Scientist, The Ottawa Hospital Research Institute
Ari Green, Chief, Division of Neuroinflammation and Glial Biology, Medical Director, Multiple Sclerosis and Neuroinflammation Center, UCSF
Tanuja Chitnis, Professor of Neurology, Harvard Medical School
Cyndi Zagieboylo, President and CEO, National MS Society
Moderated by Mandy Jackson, Managing Editor of US Commercial News for Scrip and The Pink Sheet
11:35 – 12:30 Session III: New Directions in MS Therapies
Ralph Kern, President and Chief Medical Officer, Brainstorm Cell Therapeutics
Dan Lorrain, Chief Scientific Officer, Pipeline Therapeutics
Joachim Herz, Professor, Molecular Genetics, Neuroscience, Neurology; Director, Center for Translational Neurodegeneration Research, UT Southwestern Medical Center
Krish Ramanathan, Global Program Head, Neuroscience and Global Drug Development, Novartis
Moderated by Richard Soll, Head of WuXi AppTec’s Boston office; Senior Advisor of Strategic Initiatives
As an industry enabler, WuXi AppTec is committed to improving the lives of patients globally. We share the conviction that we must work collaboratively to solve industry-wide challenges and bring transformative medicines to patients.
This event is complimentary and open to the public. We welcome you to the conversation.
Contact: Peter Zhu
Contact Email: email@example.com